Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04240327 · ClinicalTrials.gov registry record
Marker Driven Selection of Patients for Prostate Biopsy and Management
A clinical trial of Prostate Cancer and PSA, sponsored by University of Miami.
- Active
- Registry status
- 289
- Enrollment target
- 1
- Study location
NCT04240327 is a study of Prostate Cancer and PSA that is active but no longer recruiting, run by University of Miami. The registered enrollment target is 289 participants, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (52% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04240327, a study of Prostate Cancer and PSA, is active but no longer recruiting, sponsored by University of Miami.
- ACTIVE NOT RECRUITING
- Registry status
- 289 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research study is to determine if the interpretation of multiparametric MRI (mpMRI) with an algorithm called habitat risk score (HRS) in combination with a panel of blood and urine biomarkers is more effective at detecting prostate cancer than standard of care interpretation of mpMRI with the Prostate Imaging Reporting and Data System (PIRADS).
Conditions Studied
Study Locations (1)
Florida
- University of Miami - Miami
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 289 participants |
| Start Date | 2020-06-29 |
| Est. Completion | 2027-06-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04240327
The ClinicalTrials.gov registry entry for NCT04240327 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 289 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (52% lower). The listed sponsor is University of Miami, which has 721 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Prostate Cancer appearing as the primary indexed condition, and to 0 interventions.
NCT04240327 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.
Frequently Asked Questions
What is clinical trial NCT04240327 about?
NCT04240327 is a clinical study titled "Marker Driven Selection of Patients for Prostate Biopsy and Management". The purpose of this research study is to determine if the interpretation of multiparametric MRI (mpMRI) with an algorithm called habitat risk score (HRS) in combination with a panel of blood and urine biomarkers is more effective at detecting prostate cancer than standard of care interpretation of m...
What is the current status of trial NCT04240327?
This trial is currently active not recruiting. The enrollment target is 289 participants. The study started on 2020-06-29. Estimated completion is 2027-06-01.
What conditions does trial NCT04240327 study?
This clinical trial studies the following conditions: Prostate Cancer, PSA, Elevated PSA.
Who is sponsoring clinical trial NCT04240327?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04240327 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Prostate Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Study to Evaluate Safety, Efficacy, and Pharmacokinetics in Participants With Advanced Solid Tumors
RECRUITING · Phase 1
-
Performance of Inherited Risk Assessment for Predicting Prostate Cancer From Prostate Biopsy
RECRUITING
-
Trial of Neoadjuvant Enoblituzumab vs SOC in Men With High-Risk Localized Prostate Cancer
RECRUITING · Phase 2
-
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
RECRUITING
-
Improving Health Literacy in African-American Prostate Cancer Patients
RECRUITING · NA
-
Phase 1 Trial of ZM008 as Single Agent and in Combination With Pembrolizumab in Patients With Advanced Solid Tumors
RECRUITING · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.